Ultrasound-guided axillary vein versus internal jugular vein access for totally implantable venous access ports in breast cancer: a retrospective comparison of patient-reported outcomes.

ABSTRACT:

Background

Patient-centered venous access is critical in breast cancer supportive care. While the tunnel-less axillary vein (AxV) approach for totally implantable venous access port (TIVAP) implantation may improve patient experience, comparative evidence on patient-reported outcomes (PROs) against the standard internal jugular vein (IJV) approach remains limited.

Methods

This single-center retrospective cohort study compared ultrasound-guided IJV (n = 106) versus AxV (n = 102) TIVAP implantation in breast cancer patients (September 2020-February 2025). Primary outcomes included postoperative comfort (assessed at 1 day) and cosmetic outcome and satisfaction (assessed at 6 months). Complications were monitored for 6 months. Group comparisons utilized chi-square/Fisher's exact

SUBMITTER: He J 

PROVIDER: S-EPMC12630992 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature